No Data
No Data
There Might Be More To Harbin Medisan Pharmaceutical's (SZSE:002900) Story Than Just Weak Earnings
Harbin Medisan Pharmaceutical Co., Ltd. (SZSE:002900) CEO Jian Fei Qin's Holdings Dropped 13% in Value as a Result of the Recent Pullback
We Think That There Are More Issues For Harbin Medisan Pharmaceutical (SZSE:002900) Than Just Sluggish Earnings
Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation
4.1% Earnings Growth Over 3 Years Has Not Materialized Into Gains for Harbin Medisan Pharmaceutical (SZSE:002900) Shareholders Over That Period
Harbin Medisan Pharmaceutical Co., Ltd. (SZSE:002900) Held Back By Insufficient Growth Even After Shares Climb 26%